Evidence map›Paper›PMID 28108543›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Katherine Tarlock, Todd A Alonzo, Michael R Loken, Robert B Gerbing, Rhonda E Ries, Richard Aplenc, Lillian Sung, Susana C Raimondi, Betsy A Hirsch, Samir B Kahwash and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia.Asian Pacific journal of cancer prevention : APJCP · 2019
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Katherine TarlockClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. ktarlock@fredhutch.org.
Todd A AlonzoChildren's Oncology Group, Monrovia, California.
Michael R LokenHematologics, Inc., Seattle, Washington.
Robert B GerbingChildren's Oncology Group, Monrovia, California.
Rhonda E RiesDepartment of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington.
Richard AplencDivision of Hematology/Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Lillian SungDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario.
Susana C RaimondiSt. Jude Children's Research Hospital, Memphis, Tennessee.
Betsy A HirschDivision of Laboratory Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
Samir B KahwashNationwide Children's Hospital, Columbus, Ohio.
Amy McKenneyCleveland Clinic Foundation, Cleveland, Ohio.
E Anders KolbNemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware.
Alan S GamisChildren's Mercy Hospitals and Clinics, Kansas City, Missouri.
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cleveland Clinic · USUniversity of Southern California · US

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
COG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
Children's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI DEVIDAS, MEENAKSHI · 2003 to 2013
$67.5M
Biology/prognostic implications of Flt3 mutations in AMLR01CA114563 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MESHINCHI, SOHEIL · 2005 to 2016
$4.4M
NCI NIH HHS R01 CA114563NCI NIH HHS U10 CA098413NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PrognosisAdolescentAdultChildChild, PreschoolDisease-Free SurvivalFemaleFlow Cytometryfms-Like Tyrosine Kinase 3Gene Expression Regulation, NeoplasticHistone-Lysine N-MethyltransferaseHumansInfantLeukemia, Myeloid, AcuteMaleMutationFLT3 protein, humanfms-Like Tyrosine Kinase 3Histone-Lysine N-MethyltransferaseKMT2A protein, humanMyeloid-Lymphoid Leukemia ProteinReceptors, Cell Surface

Identifiers

PMID28108543
PMCPMC5511553
OpenAlexW2576009444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.